The study of Golgi apparatus in Alzheimer's disease

被引：28

作者：

Hu, Zhiping ^{[1
]}

Zeng, Liuwang ^{[1
]}

Huang, Zhiling ^{[1
]}

Zhang, Jie ^{[1
]}

Li, Ting ^{[1
]}

机构：

[1] Cent S Univ, Xiangya Hosp 2, Dept Neurol, Changsha 410011, Peoples R China

来源：

NEUROCHEMICAL RESEARCH | 2007年 / 32卷 / 08期

关键词：

Golgi apparatus; Alzheimer's disease; amyloid beta-protein; amyloid precursor protein; presenilins; gamma-secretase; tau;

D O I：

10.1007/s11064-007-9302-4

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Alzheimer's disease is an irreversible, progressive neurodegenerative disorder leading invariably to death, usually within 7-10 years after diagnosis and is the leading cause of dementia in the elderly. Not only is Alzheimer's disease a tragic disease in which people suffer from neurodegeneration in the years to come, it also becomes an incredible burden on the public health system. However, there is currently no effective treatment to halt the progression or prevent the onset of Alzheimer's disease. This is partly due to the fact that the complex pathophysiology of Alzheimer's disease is not yet completely understood. Recently, Golgi apparatus is found to play an important role in Alzheimer's disease. In this review, we discuss the changes of Golgi apparatus during clinical progression and pathological development of Alzheimer's disease. First, changes of Golgi apparatus size in Alzheimer's disease are summarized. We then address the role of Golgi apparatus in the neuropathology of Alzheimer's disease. Finally, the role of Golgi apparatus in the pathogenesis of Alzheimer's disease is discussed. Understanding the contribution of Golgi apparatus dysfunction to Alzheimer's disease and its pathophysiological basis will significantly impact our ability to develop more effective therapies for Alzheimer's disease.

引用

页码：1265 / 1277

页数：13

共 92 条

[41] Presenilin-1 affects trafficking and processing of βAPP and is targeted in a complex with nicastrin to the plasma membrane [J].

Kaether, C ;

Lammich, S ;

Edbauer, D ;

Ertl, M ;

Rietdorf, J ;

Capell, A ;

Steiner, H ;

Haass, C .

JOURNAL OF CELL BIOLOGY, 2002, 158 (03) :551-561

[42] Mutant presenilin (A260V) affects Rab8 in PC12D cell [J].

Kametani, F ;

Usami, M ;

Tanaka, K ;

Kume, H ;

Mori, H .

NEUROCHEMISTRY INTERNATIONAL, 2004, 44 (05) :313-320

[43] Presenilin-1 and its N-terminal and C-terminal fragments are transported in the sciatic nerve of rat [J].

Kasa, P ;

Papp, H ;

Pakaski, M .

BRAIN RESEARCH, 2001, 909 (1-2) :159-169

[44]

Kawamata T, 1998, J NEUROSCI, V18, P7402

[45] Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease [J].

LaFerla, FM .

NATURE REVIEWS NEUROSCIENCE, 2002, 3 (11) :862-872

[46] Presenilin 1 is required for maturation and cell surface accumulation of nicastrin [J].

Leem, JY ;

Vijayan, S ;

Han, P ;

Cai, DM ;

Machura, M ;

Lopes, KO ;

Veselits, ML ;

Xu, HX ;

Thinakaran, G .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (21) :19236-19240

[47] Alzheimer's presenilin-1 mutation potentiates inositol 1,4,5-trisphosphate-mediated calcium signaling in Xenopus oocytes [J].

Leissring, MA ;

Paul, BA ;

Parker, I ;

Cotman, CW ;

LaFerla, FM .

JOURNAL OF NEUROCHEMISTRY, 1999, 72 (03) :1061-1068

[48] Presenilin-2 mutations modulate amplitude and kinetics of inositol 1,4,5-trisphosphate-mediated calcium signals [J].

Leissring, MA ;

Parker, I ;

LaFerla, FM .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (46) :32535-32538

[49] Fragmentation of the Golgi apparatus induced by the overexpression of wild-type and mutant human tau forms in neurons [J].

Liazoghli, D ;

Perreault, S ;

Micheva, KD ;

Desjardins, M ;

Leclerc, N .

AMERICAN JOURNAL OF PATHOLOGY, 2005, 166 (05) :1499-1514

[50] Calsenilin enhances apoptosis by altering endoplasmic reticulum calcium signaling [J].

Lilliehook, C ;

Chan, S ;

Choi, EK ;

Zaidi, NF ;

Wasco, W ;

Mattson, MP ;

Buxbaum, JD .

MOLECULAR AND CELLULAR NEUROSCIENCE, 2002, 19 (04) :552-559

← 1 2 3 4 5 6 7 8 9 10 →